Eversept Partners LP Acquires 409,279 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)

Eversept Partners LP grew its holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX – Get Rating) by 33.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,620,713 shares of the company’s stock after purchasing an additional 409,279 shares during the quarter. Syndax Pharmaceuticals comprises 3.8% of […]

Related Keywords

Arizona ,United States ,Florida ,Eckard Weber ,Richarda Heyman ,Ronaldm Evans ,Briggs Morrison ,Peter Ordentlich ,Citigroup ,Manufacturers Life Insurance Company ,Jpmorgan Chase Co ,Nasdaq ,Syndax Pharmaceuticals ,Goldman Sachs Group ,Board Of Administration Florida Retirement System ,News Ratings For Syndax Pharmaceuticals Daily ,Quarter For Syndax Pharmaceuticals ,Securities Exchange Commission ,Pricet Rowe Associates Inc ,Syndax Pharmaceuticals Inc ,Syndax Pharmaceuticals Stock Down ,Eversept Partners ,Get Rating ,Florida Retirement System ,State Retirement System ,Pricet Rowe Associates ,Director Briggs Morrison ,Exchange Commission ,Pharmaceuticals Stock Down ,Michael Downes ,Syndax Pharmaceuticals Daily ,Nasdaq Sndx ,Sndx ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,